Biological Drugs-Global Market Status and Trend Report 2015-2026

  • Product Code:
    RP-ID-10347254
  • Published Date:
    30 Apr 2021
  • Region:
    Global
  • Pages:
    142
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-30

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Report Summary

Biological Drugs-Global Market Status and Trend Report 2015-2026 offers a comprehensive analysis on Biological Drugs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Worldwide and Regional Market Size of Biological Drugs 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Biological Drugs worldwide, with company and product introduction, position in the Biological Drugs market

Market status and development trend of Biological Drugs by types and applications
Cost and profit status of Biological Drugs, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Biological Drugs market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Biological Drugs industry.

The report segments the global Biological Drugs market as:

Global Biological Drugs Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America
Europe
China
Japan
Rest APAC
Latin America

Global Biological Drugs Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
Therapeutic Protein
Monoclonal Antibody
Vaccine
Others

Global Biological Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Hospitals
Ambulatory Surgical Centers
Others

Global Biological Drugs Market: Manufacturers Segment Analysis (Company and Product introduction, Biological Drugs Sales Volume, Revenue, Price and Gross Margin):
Bristol-Myers Squibb
Merck
Pfizer
Eli Lilly
Johnson & Johnson
Takeda
Baxter
F. Hoffmann-La Roche
Amgen
Abbott Laboratories
Novartis
Biogen
GlaxoSmithKline

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents
Chapter 1 Overview of Biological Drugs
1.1 Definition of Biological Drugs in This Report
1.2 Commercial Types of Biological Drugs
1.2.1 Therapeutic Protein
1.2.2 Monoclonal Antibody
1.2.3 Vaccine
1.2.4 Others
1.3 Downstream Application of Biological Drugs
1.3.1 Hospitals
1.3.2 Ambulatory Surgical Centers
1.3.3 Others
1.4 Development History of Biological Drugs
1.5 Market Status and Trend of Biological Drugs 2015-2026
1.5.1 Global Biological Drugs Market Status and Trend 2015-2026
1.5.2 Regional Biological Drugs Market Status and Trend 2015-2026
Chapter 2 Global Market Status and Forecast by Regions
2.1 Market Development of Biological Drugs 2015-2019
2.2 Production Market of Biological Drugs by Regions
2.2.1 Production Volume of Biological Drugs by Regions
2.2.2 Production Value of Biological Drugs by Regions
2.3 Demand Market of Biological Drugs by Regions
2.4 Production and Demand Status of Biological Drugs by Regions
2.4.1 Production and Demand Status of Biological Drugs by Regions 2015-2019
2.4.2 Import and Export Status of Biological Drugs by Regions 2015-2019
Chapter 3 Global Market Status and Forecast by Types
3.1 Production Volume of Biological Drugs by Types
3.2 Production Value of Biological Drugs by Types
3.3 Market Forecast of Biological Drugs by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
4.1 Demand Volume of Biological Drugs by Downstream Industry
4.2 Market Forecast of Biological Drugs by Downstream Industry
Chapter 5 Market Driving Factor Analysis of Biological Drugs
5.1 Global Economy Situation and Trend Overview
5.2 Biological Drugs Downstream Industry Situation and Trend Overview
Chapter 6 Biological Drugs Market Competition Status by Major Manufacturers
6.1 Production Volume of Biological Drugs by Major Manufacturers
6.2 Production Value of Biological Drugs by Major Manufacturers
6.3 Basic Information of Biological Drugs by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Biological Drugs Major Manufacturer
6.3.2 Employees and Revenue Level of Biological Drugs Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
Chapter 7 Biological Drugs Major Manufacturers Introduction and Market Data
7.1 Bristol-Myers Squibb
7.1.1 Company profile
7.1.2 Representative Biological Drugs Product
7.1.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Bristol-Myers Squibb
7.2 Merck
7.2.1 Company profile
7.2.2 Representative Biological Drugs Product
7.2.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Merck
7.3 Pfizer
7.3.1 Company profile
7.3.2 Representative Biological Drugs Product
7.3.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Pfizer
7.4 Eli Lilly
7.4.1 Company profile
7.4.2 Representative Biological Drugs Product
7.4.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Eli Lilly
7.5 Johnson & Johnson
7.5.1 Company profile
7.5.2 Representative Biological Drugs Product
7.5.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.6 Takeda
7.6.1 Company profile
7.6.2 Representative Biological Drugs Product
7.6.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Takeda
7.7 Baxter
7.7.1 Company profile
7.7.2 Representative Biological Drugs Product
7.7.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Baxter
7.8 F. Hoffmann-La Roche
7.8.1 Company profile
7.8.2 Representative Biological Drugs Product
7.8.3 Biological Drugs Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche
7.9 Amgen
7.9.1 Company profile
7.9.2 Representative Biological Drugs Product
7.9.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Amgen
7.10 Abbott Laboratories
7.10.1 Company profile
7.10.2 Representative Biological Drugs Product
7.10.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.11 Novartis
7.11.1 Company profile
7.11.2 Representative Biological Drugs Product
7.11.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Novartis
7.12 Biogen
7.12.1 Company profile
7.12.2 Representative Biological Drugs Product
7.12.3 Biological Drugs Sales, Revenue, Price and Gross Margin of Biogen
7.13 GlaxoSmithKline
7.13.1 Company profile
7.13.2 Representative Biological Drugs Product
7.13.3 Biological Drugs Sales, Revenue, Price and Gross Margin of GlaxoSmithKline
Chapter 8 Upstream and Downstream Market Analysis of Biological Drugs
8.1 Industry Chain of Biological Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
Chapter 9 Cost and Gross Margin Analysis of Biological Drugs
9.1 Cost Structure Analysis of Biological Drugs
9.2 Raw Materials Cost Analysis of Biological Drugs
9.3 Labor Cost Analysis of Biological Drugs
9.4 Manufacturing Expenses Analysis of Biological Drugs
Chapter 10 Marketing Status Analysis of Biological Drugs
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Report Conclusion
Chapter 12 Research Methodology and Reference
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Bristol-Myers Squibb
Merck
Pfizer
Eli Lilly
Johnson & Johnson
Takeda
Baxter
F. Hoffmann-La Roche
Amgen
Abbott Laboratories
Novartis
Biogen
GlaxoSmithKline

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports